Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) Operating Expenses (2020 - 2025)

Historic Operating Expenses for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to $19.2 million.

  • Rapid Micro Biosystems' Operating Expenses fell 220.43% to $19.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.9 million, marking a year-over-year decrease of 270.99%. This contributed to the annual value of $78.0 million for FY2024, which is 140.61% down from last year.
  • Per Rapid Micro Biosystems' latest filing, its Operating Expenses stood at $19.2 million for Q3 2025, which was down 220.43% from $19.4 million recorded in Q2 2025.
  • Rapid Micro Biosystems' Operating Expenses' 5-year high stood at $21.6 million during Q4 2022, with a 5-year trough of $14.7 million in Q1 2021.
  • Moreover, its 5-year median value for Operating Expenses was $19.4 million (2025), whereas its average is $19.2 million.
  • In the last 5 years, Rapid Micro Biosystems' Operating Expenses skyrocketed by 9746.66% in 2021 and then tumbled by 1437.09% in 2023.
  • Rapid Micro Biosystems' Operating Expenses (Quarter) stood at $19.8 million in 2021, then rose by 9.46% to $21.6 million in 2022, then decreased by 14.37% to $18.5 million in 2023, then dropped by 0.42% to $18.4 million in 2024, then rose by 4.14% to $19.2 million in 2025.
  • Its Operating Expenses was $19.2 million in Q3 2025, compared to $19.4 million in Q2 2025 and $18.9 million in Q1 2025.